Track the Embecta Corp. stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Health Care sector, Embecta Corp. has published 86 reports. Market capitalisation: €178.9m. The latest transaction was filed on 23 May 2025 (Acquisition). Among the most active insiders: Kurdikar Devdatt. All data is free.
86
Insider Decl.
0
Thresholds
€857,954
9 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Embecta Corp. Hold (neutral), based on 2 analysts. Average price target: US$8.00.
40Σ signal
Buys €857,954· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,187 of 25,535 companies
75.2
score / 100
Value
95
Quality
55
FCF yld99%
Earn yld52%
EV/EBITDA5.7x
ROE·
Gross mgn63%
Net mgn8.8%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.